IHC
Human endometrial adenocarcinoma tissue was stained with Anti-Wilms' Tumor 1 Antibody.| Product Name | Mouse Monoclonal Antibody to Wilms' Tumor 1 |
|---|---|
| Antibody Type | Primary Antibodies |
| Immunogen | Synthesized peptide derived from human Wilms' Tumor 1(WT1) AA range: 350-449. |
| Clonality | Monoclonal |
|---|---|
| Isotype | IgG2b,k |
| Host Species | Mouse |
| Tested Applications | IHC |
| IHC:1:50-1:100 |
|
| Species Reactivity | HumanMousePigRat |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Symbol | WT1 |
|---|---|
| Gene Synonyms | GUD AWT1 WAGR WT-1 WT33 NPHS4 WIT-2 |
| Gene Full Name | WT1 transcription factor |
| Gene Summary | This gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilms tumor. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation codon upstream of, and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated. [provided by RefSeq, Mar 2015] |
| Molecular Weight(MW) | 55 kDa |
| Cellular Localization | Cytoplasm,Nucleus. |
IHC
Human endometrial adenocarcinoma tissue was stained with Anti-Wilms' Tumor 1 Antibody.| Application Notes | IHC:1:50-1:100 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | -15°C to -25°C/1 year(Do not lower than -25°C). |
| Storage Buffer | PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA. |
